KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rigel Pharmaceuticals (RIGL) Times Interest Earned (2019 - 2025)

Rigel Pharmaceuticals has reported Times Interest Earned over the past 9 years, most recently at $13.64 for Q4 2025.

  • Quarterly results put Times Interest Earned at $13.64 for Q4 2025, up 60.08% from a year ago — trailing twelve months through Dec 2025 was $17.14 (up 460.99% YoY), and the annual figure for FY2025 was $17.14, up 460.99%.
  • Times Interest Earned for Q4 2025 was $13.64 at Rigel Pharmaceuticals, down from $15.01 in the prior quarter.
  • Over the last five years, Times Interest Earned for RIGL hit a ceiling of $86.09 in Q1 2021 and a floor of -$22.79 in Q2 2022.
  • Median Times Interest Earned over the past 5 years was -$1.07 (2024), compared with a mean of $2.37.
  • Biggest five-year swings in Times Interest Earned: tumbled 207.17% in 2022 and later skyrocketed 14700.2% in 2025.
  • Rigel Pharmaceuticals' Times Interest Earned stood at -$16.49 in 2021, then skyrocketed by 111.39% to $1.88 in 2022, then tumbled by 45.11% to $1.03 in 2023, then surged by 726.35% to $8.52 in 2024, then surged by 60.08% to $13.64 in 2025.
  • The last three reported values for Times Interest Earned were $13.64 (Q4 2025), $15.01 (Q3 2025), and $32.61 (Q2 2025) per Business Quant data.